Vanderbilt University Ingram Cancer Center — Nashville, Tennessee

Vanderbilt University Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37212.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Vanderbilt University Ingram Cancer Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, KRAS p.G12C Mutant Advanced Solid Tumors.

Sponsors: Jazz Pharmaceuticals, Amgen, Laura Huppert, MD, BA.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt University Ingram Cancer Center?

Vanderbilt University Ingram Cancer Center has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt University Ingram Cancer Center conducted?

Vanderbilt University Ingram Cancer Center has 4 clinical trials on record, with 2 currently active. Their work covers Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, KRAS p.G12C Mutant Advanced Solid Tumors.

Is Vanderbilt University Ingram Cancer Center accredited by Crixeo Health?

Vanderbilt University Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt University Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.